FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386213033> ?p ?o ?g. }

• W4386213033 abstract "Objective This study aims to explore the potential anti-cancer properties of boric acid (BA) in human endometrial cancer Ishikawa cells by assessing its influence on cell viability, apoptosis, oxidative stress, and inflammatory responses. Methods The impact of BA at concentrations ranging from 2.5 to 100 mM on cell viability was assessed in Ishikawa cells and normal fibroblast L929 cells (used as the control) through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Spectrophotometric measurements were performed to determine the total oxidant status (TOS) and total antioxidant status (TAS) in BA-treated cells, and the oxidative stress index (OSI) was calculated. The enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of cytochrome c and caspase 3, both of which are constituents of the extrinsic apoptotic pathway. Furthermore, changes in the concentrations of pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β) in the cells were analyzed using ELISA and immunofluorescence staining. Results The exposure of Ishikawa cells to BA for 24 hours led to a dose-dependent decline in cell viability, with an IC50 value of 40 mM. BA dose-dependently increased cytochrome c and caspase 3 levels in cancer cells. In Ishikawa cells, BA treatment led to a significant elevation in OSI. Moreover, the concentrations of TNF-α and IL-1β exhibited a dose-dependent decrease in BA-treated cells. On the other hand, in L929 cells, BA decreased OSI in a dose-dependent manner but did not change TNF-α and IL-1β levels. Concentrations up to 80 mM had no effect on cell viability and apoptosis, but BA at 80 mM concentration decreased viability and increased cytochrome c and caspase 3 levels in L929 cells. Conclusion BA inhibited cell viability, triggered apoptosis, induced oxidative stress, and suppressed inflammatory responses in endometrial cancer cells. Notably, at its IC50 concentration, BA had no cytotoxic effect on normal fibroblasts. Given its favorable properties, BA may provide a valuable therapeutic option to impede the development and progression of endometrial cancer." @default.
• W4386213033 created "2023-08-29" @default.
• W4386213033 creator A5017233540 @default.
• W4386213033 creator A5041847189 @default.
• W4386213033 creator A5047097093 @default.
• W4386213033 creator A5085532657 @default.
• W4386213033 creator A5092705959 @default.
• W4386213033 date "2023-08-28" @default.
• W4386213033 modified "2023-10-17" @default.
• W4386213033 title "Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells" @default.
• W4386213033 cites W1966916878 @default.
• W4386213033 cites W1974687591 @default.
• W4386213033 cites W2014003988 @default.
• W4386213033 cites W2018692554 @default.
• W4386213033 cites W2033882650 @default.
• W4386213033 cites W2073068414 @default.
• W4386213033 cites W2121754708 @default.
• W4386213033 cites W2125063590 @default.
• W4386213033 cites W2131785771 @default.
• W4386213033 cites W2147099793 @default.
• W4386213033 cites W2147388422 @default.
• W4386213033 cites W2163009668 @default.
• W4386213033 cites W2586149603 @default.
• W4386213033 cites W2765952964 @default.
• W4386213033 cites W2797029430 @default.
• W4386213033 cites W2944317251 @default.
• W4386213033 cites W2945771376 @default.
• W4386213033 cites W2993224640 @default.
• W4386213033 cites W3041426930 @default.
• W4386213033 cites W3092384021 @default.
• W4386213033 cites W3175826328 @default.
• W4386213033 cites W3180882235 @default.
• W4386213033 cites W4206540966 @default.
• W4386213033 cites W4213227339 @default.
• W4386213033 cites W4285605921 @default.
• W4386213033 cites W4309012759 @default.
• W4386213033 cites W4324045067 @default.
• W4386213033 cites W4381431712 @default.
• W4386213033 doi "https://doi.org/10.7759/cureus.44277" @default.
• W4386213033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37772231" @default.
• W4386213033 hasPublicationYear "2023" @default.
• W4386213033 type Work @default.
• W4386213033 citedByCount "0" @default.
• W4386213033 crossrefType "journal-article" @default.
• W4386213033 hasAuthorship W4386213033A5017233540 @default.
• W4386213033 hasAuthorship W4386213033A5041847189 @default.
• W4386213033 hasAuthorship W4386213033A5047097093 @default.
• W4386213033 hasAuthorship W4386213033A5085532657 @default.
• W4386213033 hasAuthorship W4386213033A5092705959 @default.
• W4386213033 hasBestOaLocation W43862130331 @default.
• W4386213033 hasConcept C121608353 @default.
• W4386213033 hasConcept C126322002 @default.
• W4386213033 hasConcept C134018914 @default.
• W4386213033 hasConcept C153911025 @default.
• W4386213033 hasConcept C16685009 @default.
• W4386213033 hasConcept C17991360 @default.
• W4386213033 hasConcept C190283241 @default.
• W4386213033 hasConcept C2776151105 @default.
• W4386213033 hasConcept C2780783641 @default.
• W4386213033 hasConcept C502942594 @default.
• W4386213033 hasConcept C53227056 @default.
• W4386213033 hasConcept C55493867 @default.
• W4386213033 hasConcept C71924100 @default.
• W4386213033 hasConcept C86803240 @default.
• W4386213033 hasConcept C96232424 @default.
• W4386213033 hasConceptScore W4386213033C121608353 @default.
• W4386213033 hasConceptScore W4386213033C126322002 @default.
• W4386213033 hasConceptScore W4386213033C134018914 @default.
• W4386213033 hasConceptScore W4386213033C153911025 @default.
• W4386213033 hasConceptScore W4386213033C16685009 @default.
• W4386213033 hasConceptScore W4386213033C17991360 @default.
• W4386213033 hasConceptScore W4386213033C190283241 @default.
• W4386213033 hasConceptScore W4386213033C2776151105 @default.
• W4386213033 hasConceptScore W4386213033C2780783641 @default.
• W4386213033 hasConceptScore W4386213033C502942594 @default.
• W4386213033 hasConceptScore W4386213033C53227056 @default.
• W4386213033 hasConceptScore W4386213033C55493867 @default.
• W4386213033 hasConceptScore W4386213033C71924100 @default.
• W4386213033 hasConceptScore W4386213033C86803240 @default.
• W4386213033 hasConceptScore W4386213033C96232424 @default.
• W4386213033 hasLocation W43862130331 @default.
• W4386213033 hasLocation W43862130332 @default.
• W4386213033 hasOpenAccess W4386213033 @default.
• W4386213033 hasPrimaryLocation W43862130331 @default.
• W4386213033 hasRelatedWork W1977918131 @default.
• W4386213033 hasRelatedWork W1990717759 @default.
• W4386213033 hasRelatedWork W2023082526 @default.
• W4386213033 hasRelatedWork W2347359022 @default.
• W4386213033 hasRelatedWork W2359987915 @default.
• W4386213033 hasRelatedWork W2362948099 @default.
• W4386213033 hasRelatedWork W2366761680 @default.
• W4386213033 hasRelatedWork W2367454707 @default.
• W4386213033 hasRelatedWork W2501960686 @default.
• W4386213033 hasRelatedWork W2477965377 @default.
• W4386213033 isParatext "false" @default.
• W4386213033 isRetracted "false" @default.
• W4386213033 workType "article" @default.